ADAM22 Antikörper (N-Term)
Kurzübersicht für ADAM22 Antikörper (N-Term) (ABIN928107)
Target
Alle ADAM22 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Kreuzreaktivität
- Maus
-
Aufreinigung
- Purified
-
Immunogen
- Adam22 antibody was raised in rabbit using the N terminal of Adam22 as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
Adam22 Blocking Peptide, , is also available for use as a blocking control in assays to test for specificity of this Adam22 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- ADAM22 (ADAM Metallopeptidase Domain 22 (ADAM22))
-
Andere Bezeichnung
- Adam22
-
Hintergrund
- Adam22 is a probable ligand for integrin in the brain. This is a non catalytic metalloprotease-like protein. Adam22 is involved in regulation of cell adhesion and spreading and in inhibition of cell proliferation.Adam22 is asneuronal receptor for LGI1. Synonyms: Polyclonal Adam22 antibody, Anti-Adam22 antibody, a disintegrin and metallopeptidase domain 22 antibody, 2900022I03Rik antibody, AI854032 antibody, MDC2 antibody.
Target
-